Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 3
2007 3
2008 2
2009 1
2010 5
2011 2
2012 3
2013 2
2014 4
2015 5
2016 5
2017 4
2018 11
2019 10
2020 9
2021 21
2022 12
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
The Effect of a Web-Based Cervical Cancer Survivor's Story on Parents' Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial.
Suzuki Y, Sukegawa A, Ueda Y, Sekine M, Enomoto T, Melamed A, Wright JD, Miyagi E. Suzuki Y, et al. Among authors: sekine m. JMIR Public Health Surveill. 2022 May 25;8(5):e34715. doi: 10.2196/34715. JMIR Public Health Surveill. 2022. PMID: 35421848 Free PMC article. Clinical Trial.
Japan's Ongoing Crisis on HPV Vaccination.
Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Sekine M, et al. Vaccines (Basel). 2020 Jul 6;8(3):362. doi: 10.3390/vaccines8030362. Vaccines (Basel). 2020. PMID: 32640691 Free PMC article. Review.
HPV vaccination in Japan: what is happening in Japan?
Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, Miyagi E, Sekine M, Enomoto T, Kudoh K. Ikeda S, et al. Among authors: sekine m. Expert Rev Vaccines. 2019 Apr;18(4):323-325. doi: 10.1080/14760584.2019.1584040. Epub 2019 Feb 22. Expert Rev Vaccines. 2019. PMID: 30768373 No abstract available.
Cervical Cancer Protection in Japan: Where Are We?
Yagi A, Ueda Y, Kakuda M, Nakagawa S, Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, Kurosawa M, Yamaguchi M, Adachi S, Kudo R, Sekine M, Suzuki Y, Sukegawa A, Ikeda S, Miyagi E, Enomoto T, Kimura T. Yagi A, et al. Among authors: sekine m. Vaccines (Basel). 2021 Nov 1;9(11):1263. doi: 10.3390/vaccines9111263. Vaccines (Basel). 2021. PMID: 34835194 Free PMC article. Review.
Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study.
Yoshihara K, Baba T, Tokunaga H, Nishino K, Sekine M, Takamatsu S, Matsumura N, Yoshida H, Kajiyama H, Shimada M, Kagimura T, Oda K, Sasajima Y, Yaegashi N, Okamoto A, Sugiyama T, Enomoto T. Yoshihara K, et al. Among authors: sekine m. Cancer Sci. 2023 Jun;114(6):2515-2523. doi: 10.1111/cas.15747. Epub 2023 Apr 10. Cancer Sci. 2023. PMID: 36747324 Free PMC article.
94 results